Morning Briefing
Summaries of health policy coverage from major news organizations
Viewpoints: Without Restructuring, HIV Cure May Harm Survivors; Melanoma Vaccine Trials Spark Hope For Other Cancers
Editorial writers examine these public health issues.
Stat: A Cure For HIV Would Be A Triumph. But It Shouldn’t Harm Survivors
We need safeguards so long-term survivors don't lose benefits. (Ali Ahmed, Jeff Taylor, and Jeff Berry, 8/21)
Bloomberg: Moderna And Merck's Cancer Vaccine Is The Advance We've Been Waiting For
Scientists are on the cusp of fulfilling a decades-long quest: to use vaccines to teach the immune system to spot and destroy cancer cells. (Lisa Jarvis, 8/21)
The Washington Post: A Cancer Vaccine Interrupts A Technology Backlash
The Moderna-Merck breakthrough reflects advances in genomics and computing. (8/20)
The Washington Post: A Cancer Vaccine Shows Promise. Thank The Free Market.
Helping patients and making money are not mutually exclusive. (Tom Price, 8/21)
Stat: Lil Nas X’s Bipolar Diagnosis And Mental Health Treatment
We continue to romanticize the symptoms of mental health problems, especially when we talk about achievement. (Rachel Docekal, 8/21)
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
